NXT USA has announced the launch of Digexin under the brand name Motility in Brazil, in partnership with healthcare product company Infinity Pharma Brazil.

Digexin is a blend of tender okra pod and winter cherry root extracts, formulated to support both a healthy gut microbiome and improved stress management, sleep quality, mood, and energy levels, as supported by clinical studies.

The ingredient is suitable for people with chronic or occasional constipation, and is evidenced to improve digestion and intestinal transit time in just seven days, increasing frequency of bowel movements from three to seven times per week.

The launch took place at Consulfarma Congress, an event renowned for its Business Fair, which offers opportunities to view the latest advancements and product launches in the pharmaceuticals industry.

“We are thrilled to introduce Digexin as Motility in Brazil, especially at such a prestigious event,” said Eric Anderson, managing director, NXT USA. “Brazil can be a very challenging market for new dietary supplements, but with Infinity Pharma we have found a partner who can open the doors for this unique digestive health supplement to the Brazilian market through their relationships with doctors, pharmacists, and nutritionists.”

“We are very excited to bring this innovative plant-based digestive health product to the Brazilian market under the brand name Motility,” said Daniela Pavanelli, product manager with Infinity Pharma. “By promoting calm, complete digestion Motility not only addresses gastrointestinal symptoms but also contributes to mental and emotional well-being, offering unique advantages to consumers looking for digestive health support.”